Decoding the metabolic-immune axis for novel therapeutics in bladder cancer
{{output}}
Bladder cancer is a prevalent malignancy of the urinary system. Urothelial carcinoma is the predominant type, accounting for more than 90% of cases. The remaining histologic types include squamous cell carcinoma (approximately 2%-7%) and adenocarcinoma (approx... ...